Oncology Models | Charles River Discovery Services

Oncology Models 

Charles River Discovery Services offers validated human tumor xenografts, primary tumor, syngeneic, drug resistant, and specialty models in support of your drug development program. Through our broad range of service offerings and scientific expertise, our discovery team works with you to choose the most appropriate study design and screening method for an investigational agent. Depending on client needs, tumor growth delay (TGD), tumor growth inhibition (TGI), survival, combination or adjuvant design approaches may be used.  Studies can be designed to:

  • Identify leads
  • Optimize dose schedules
  • Identify optimal combination strategies
  • Evaluate drug resistance/sensitivity patterns

 

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
May 14 - New Models for Evaluating COPD or ...
May 11 - Expert Safety Testing to Accelerat...
Jun 17-Jun 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th European ...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 05-Jun 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Biol...
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA
Manager International Tax Wilmington, MA

Charles River Laboratories, Inc.